↓ Skip to main content

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

Overview of attention for article published in Journal of Translational Medicine, September 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
29 Mendeley